|
Siliq (brodalumab) approved by the US FDA for adult patients with moderate-to-severe plaque psoriasis
|
16 February 2017 |
|
Symbicort granted paediatric exclusivity in the US
|
26 January 2017 |
|
AstraZeneca expands 1st-line lung cancer Immuno-Oncology programme opportunities
|
23 January 2017 |
|
AstraZeneca and Lilly to develop second potentially disease-modifying treatment for Alzheimer's disease
|
13 January 2017 |
|
AstraZeneca takes latest scientific advances in oncology to major US and European congresses
|
29 November 2016 |
|
AstraZeneca head and neck cancer trials
|
28 October 2016 |
|
AstraZeneca enters agreement with Cilag GmbH International to divest rights to Rhinocort Aqua outside the US
|
07 October 2016 |
|
PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
|
13 September 2016 |
|
Benralizumab phase III trials show positive results in severe asthma
|
05 September 2016 |
|
AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for early Alzheimer's disease
|
22 August 2016 |